Cargando…
Involvement of proteasome β1i subunit, LMP2, on development of uterin leiomyosarcma
BACKGROUND: Although the majority of smooth muscle neoplasms found in the uterus are benign, uterine leiomyosarcoma is extremely malignant, with high rates of recurrence and metastasis. The development of gynecologic tumors is often correlated with secretion of female hormone; however, the developme...
Autores principales: | Hayashi, Takuma, Horiuchi, Akiko, Sano, Kenji, Hiraoka, Nobuyoshi, Kasai, Mari, Ichimura, Tomoyuki, Nagase, Satoru, Ishiko, Osamu, Shiozawa, Tanri, Kanai, Yae, Yaegashi, Nobuo, Aburatani, Hiroyuki, Tonegawa, Susumu, Konishi, Ikuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3271393/ https://www.ncbi.nlm.nih.gov/pubmed/22362447 http://dx.doi.org/10.4297/najms.2011.3394 |
Ejemplares similares
-
Potential role of LMP2 as tumor-suppressor defines new targets for uterine
leiomyosarcoma therapy
por: Hayashi, Takuma, et al.
Publicado: (2011) -
Molecular Approach to Uterine Leiomyosarcoma: LMP2-Deficient Mice
as an Animal Model of Spontaneous Uterine Leiomyosarcoma
por: Hayashi, Takuma, et al.
Publicado: (2011) -
Potential Biomarker for Human Uterine Leiomyosarcoma
por: Hayashi, Takuma, et al.
Publicado: (2014) -
Molecular Mechanisms of Uterine Leiomyosarcomas: Involvement of Defect in LMP2 Expression
por: Hayashi, Takuma, et al.
Publicado: (2008) -
Profiling of Target Molecules for Immunotherapy in Mesenchymal Tumors
por: Hayashi, Takuma, et al.
Publicado: (2019)